Published
July 9, 2026
Updated
September 17, 2026
The proposed nationwide Roundup class settlement would create a long-term compensation program for certain non-Hodgkin lymphoma claims.
Current Status
The final-approval hearing was rescheduled twice — from July 9 to August 19, 2026, and then by an August 6, 2026 order to September 14, 2026 — and was held on that date before Judge Timothy J. Boyer in the 22nd Judicial Circuit Court in St. Louis. The court did not rule from the bench and invited further filings from supporters and objectors, and no final-approval order has been entered. A hearing alone does not make the proposed settlement effective.StatusAwaiting final-approval order
Claim DeadlineCurrent registration period closed
Settlement ValueUp to $7.25 billion
Current MilestoneHearing held September 14, 2026
What Was This Case About?
Plaintiffs allege exposure to Roundup caused non-Hodgkin lymphoma and that Monsanto failed to adequately warn users. The defendant denied wrongdoing or liability, and the settlement does not constitute an admission.Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Who Was Covered?
Eligibility under the proposed class program depends on exposure, diagnosis, timing, and other court-approved criteria.What Benefits Were Available?
If approved, the program would offer tiered compensation and medical-monitoring-related relief under detailed eligibility rules.Official Information
Review the latest information on the Roundup class settlement website website.
Settlement Value
Up to $7.25 billion
Case Title
Roundup Cancer Class Settlement Awaiting Final Order
Court or Forum
See official settlement documents
Current Milestone
Hearing held September 14, 2026
Official Website
Roundup class settlement website
For more class actions, recalls, and refunds, keep scrolling below.
